# Guardian Lifecare Pvt.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guardian-lifecare-pvt

- Industry: Pharmaceuticals
- Headquarters: Gurgaon, India
- Website: www.guardian.in
- Total disclosed funding: $23M
- Latest round: Series A (Jun 1, 2008)
- Investors on record: 1

## About

Guardian Lifecare Pvt. Ltd., based in Gurgaon, India, is integral to the health and wellness sector, specializing in nutritional products designed to support various health and fitness needs.Founded in 2003 in Gurgaon, India, Guardian Lifecare Pvt. Ltd. focuses on nutritional products that enhance health and wellness. Under the leadership of CEO Rahul Malhotra, the company has completed three funding rounds, with its latest being a Trade Sale in August 2016, where the Taparia Family acquired a majority stake for INR 550 million. The company has not undergone significant pivots or changes in its operational strategy since inception.Guardian Lifecare Pvt. Ltd. offers a comprehensive range of nutritional products catering to health and wellness. Their product lineup includes dietary supplements like protein powders, multivitamins, omega-3 fatty acids, probiotics, and weight management solutions. These products target diverse demographics, including athletes and health-conscious consumers, focusing on needs such as muscle maintenance and recovery. Notable offerings include their Pro Performance 100% Whey Protein and AMP Gold Series, which provide essential nutrients for enhancing physical performance. The company extends its market reach beyond India to the broader Asia-Pacific region, addressing the growing demand for wellness solutions.In 2023, Guardian Lifecare Pvt. Ltd. reported a revenue of INR 0, coupled with an EBITDA of INR -8,828.3 million. The revenue generation is primarily through direct-to-consumer sales on its online platform and partnerships with various retailers and wholesalers, facilitating individual transactions that meet specific health needs.Guardian Lifecare Pvt. Ltd. aims to expand its product offerings with the launch of new nutritional products planned for the upcoming fiscal year. The company is also targeting market expansions into Southeast Asia and the Middle East by 2025 to capitalize on the increasing demand for wellness products in these regions. The funds raised from the Trade Sale will be allocated towards supporting these new product developments and market entry strategies.

## Funding rounds

- Series A, Jun 1, 2008, $23M — Samara Capital

## Investors

- Samara Capital (https://capitalatlas.ai/funds/samara-capital) — Series A